Skip to main content

Table 1 Antiviral activity of BPR1P0034.

From: Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity

 

Concentration (μM)

BPR1P0034

Amantadine

Zanamivir

IC50

CC50c

IC50

IC50

Cytotoxic effect

    

   MDCK

 

6.75 ± 0.08

  

Influenza virus

    

   A/WSN/33 (H1N1)b

0.21 ± 0.07

 

> 25

0.06 ± 0.02

   A/Udorn/72 (H3N2)a

2.11 ± 0.41

 

0.98 ± 0.15

0.67 ± 0.23

   A/TW/83/05 (H3N2)a

1.38 ± 0.08

 

> 25

0.92 ± 0.03

   A/TW/785/05 (H1N1)a

0.92 ± 0.11

 

0.38 ± 0.24

1.06 ± 0.98

   B/TW/710/05b

8.11 ± 3.98

 

> 25

0.03 ± 0.02

   B/TW/70325/05b

1.94 ± 0.72

 

> 25

0.02 ± 0.01

   B/TW/99/07b

8.90 ± 4.16

 

> 25

0.10 ± 0.01

Enterovirus 71b

    

   TW/1743/98

> 40

> 20

--

--

   TW/4643/98

> 20

> 20

--

--

Echovirus 9b

> 20

> 20

--

--

  1. MDCK cells or Vero cells were infected with influenza virus and EV71, respectively, and incubated with different concentrations of BPR1P0034.
  2. IC50was determined with a plaque reduction assaya or a neutralization assayb
  3. cCC50 was determined with an MTT assay
  4. --, not determined
  5. The values are means ± SD of 2--3 independent experiments.